Allied Health & Imaging · Independent exam preparation
TMC Examination Preparation Guide: CRT Pathway Through December 2026 Study Guide
Practise cardiopulmonary interpretation, imaging decisions, device troubleshooting, lung expansion, specialty-gas safety and ventilation decisions for the NBRC TMC examination leading to the CRT credential.
By CertMedbry · Updated 31 October 2026
Interpret conflicting respiratory data, distinguish equipment problems from patient deterioration, and choose interventions with measurable reassessment criteria. These 60 concepts selectively address all three TMC domains, with adult, pediatric and neonatal examples. The official NBRC Detailed Content Outline defines the full examination scope; this guide does not replace its complete subtopics and patient conditions.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and credential pathway does this guide cover?
This guide covers the NBRC Therapist Multiple-Choice Examination and the pathway leading to the Certified Respiratory Therapist credential. CRT is the credential awarded at the TMC low cut score, rather than the name of a separate current examination. The TMC high cut score also awards CRT and can establish Clinical Simulation Examination eligibility when the candidate meets the additional eligibility requirements. Passing TMC alone does not award RRT under this pathway.
Certified Respiratory Therapist (CRT) · NBRC Candidate Handbook
How many questions are included, and how long is the TMC examination?
The TMC examination contains 160 multiple-choice items: 140 scored items and 20 unscored pretest items. Testing time is three hours. Pretest items are interspersed, so candidates should give every item appropriate attention. These 20 original four-option learning questions are independent drills and do not predict a passing result.
Certified Respiratory Therapist (CRT) · NBRC Candidate Handbook
How is the examination delivered?
The examination is administered by computer, by appointment, at secure PSI testing locations. Candidates receive an opportunity to practise using the computer before beginning the timed examination; that practice time does not count against testing time. Breaks do not add time to the examination. Consult the current NBRC Candidate Handbook and appointment instructions for identification and testing-site requirements.
Which blueprint applies, and what changes in January 2027?
The January 2020 TMC outline applies through December 31, 2026. TMC ends on that date. The Respiratory Therapy Examination begins January 1, 2027, with a different outline, 185 multiple-choice items comprising 160 scored and 25 pretest items, and four hours of testing. Its low cut score awards CRT and its high cut score awards RRT. This guide covers the TMC blueprint through December 2026.
Certified Respiratory Therapist (CRT) · NBRC Candidate Handbook · The Respiratory Therapy Examination Detailed Content Outline
How are the TMC domains weighted in this guide?
The official scored-item allocations are Patient Data, 50 of 140; Troubleshooting and Quality Control of Devices, and Infection Control, 20 of 140; and Initiation and Modification of Interventions, 70 of 140. These are approximately 35.7%, 14.3% and 50%. This guide allocates its concepts 21/9/30, its questions 8/3/9 and its flashcards 7/3/10. The driving-pressure calculation question is classified as Patient Data because it assesses interpretation rather than treatment modification. These selective sets do not reproduce every outline subtopic or age-specific target. The official TMC outline defines the full scope.
Therapist Multiple-Choice Examination Detailed Content Outline
How are TMC scores interpreted?
Scored multiple-choice items are worth one point each, and the number answered correctly forms the raw score. NBRC compares the total with the examination's cut scores. Reaching the low cut score earns CRT; reaching the high cut score also establishes CSE eligibility when the candidate meets the applicable qualifications. Pretest items do not affect pass/fail status. Consult current NBRC scoring information for the examination you will take, and use these drills to identify reasoning gaps.
Certified Respiratory Therapist (CRT) · NBRC Candidate Handbook
How does the CRT credential relate to licensure and other respiratory examinations?
NBRC credentials support respiratory-care licensure in the United States, but each jurisdiction controls its legal practice requirements. CRT, RRT and state licensure are distinct designations. The Clinical Simulation Examination, future Respiratory Therapy Examination, pulmonary-function examination and specialty examinations have separate purposes or eligibility rules. Canadian CSRT RRT recognition appears among TMC admission routes; it does not make this guide preparation for a Canadian examination.
Certified Respiratory Therapist (CRT) · NBRC Candidate Handbook
This independently authored guide follows the Therapist Multiple-Choice Examination blueprint applicable through December 31, 2026. Clinical references support the teaching; the NBRC outline establishes examination scope.
Outline used: TMC Detailed Content Outline, effective January 2020 through December 31, 2026; verified for October 13, 2026. The workbook label Certified Respiratory Therapist (CRT) identifies the credential awarded at the TMC low cut score, rather than a separate current examination. The assigned slug is preserved. NBRC's Respiratory Therapy Examination outline becomes effective January 2027 and is not the blueprint used for this set.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Patient Data35.7% (50/140 scored items)
1.How do pH and PaCO2 identify a primary respiratory disturbance?
PaCO2 reflects the respiratory contribution to acid-base balance, while bicarbonate reflects the metabolic contribution. Acidemia with an elevated PaCO2 supports respiratory acidosis; alkalemia with a reduced PaCO2 supports respiratory alkalosis. Interpret all three values together because a second disorder can modify the pH. A near-normal pH does not establish normal ventilation when PaCO2 and bicarbonate are substantially abnormal. Connect the pattern with respiratory effort, consciousness and recent ventilatory changes.
Apply it
A drowsy patient has pH 7.26, PaCO2 60 mm Hg and bicarbonate 26 mmol/L. Identify a primary respiratory acidosis and assess ventilation immediately rather than interpreting an acceptable oxygen saturation as evidence of adequate breathing.
Common pitfall: Choosing oxygen alone because saturation is low overlooks inadequate carbon dioxide elimination; oxygenation and ventilation require separate assessment even when both are impaired.
AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013 · American Thoracic Society | Interpretation of ABGs
2.Why does bicarbonate help distinguish chronic hypercapnia from acute deterioration?
Renal bicarbonate retention partially offsets the acidifying effect of sustained hypercapnia, so chronic respiratory acidosis commonly has a higher bicarbonate than an abrupt PaCO2 rise. Compensation moves pH toward normal but does not remove the underlying ventilatory disorder. Compare the current gas with a stable baseline and the clinical time course. A substantial new fall in pH in a chronically hypercapnic patient suggests an acute component or an additional acidifying process.
Apply it
A patient's stable gas was pH 7.36 with PaCO2 55 mm Hg. During worsening somnolence, PaCO2 becomes 78 and pH 7.22. Recognize acute deterioration superimposed on chronic carbon dioxide retention and escalate respiratory assessment.
Common pitfall: Calling every elevated PaCO2 an acute emergency ignores baseline physiology; calling it usual COPD despite a new acidemia misses clinically important deterioration.
American Thoracic Society | Interpretation of ABGs · Official ERS/ATS Clinical Practice Guidelines: Noninvasive Ventilation for Acute Respiratory Failure (2017)
3.Which treatment details make serial blood gases interpretable?
A blood gas describes the patient under the conditions present when the sample was collected. Record oxygen concentration or delivery settings, ventilatory support, collection time, sample source and relevant changes in clinical status. A higher PaO2 after increasing inspired oxygen does not independently demonstrate improved gas exchange. Likewise, a PaCO2 change after altering ventilator support must be interpreted against the new settings and the patient's effort rather than compared as an isolated laboratory trend.
Apply it
PaO2 rises from 65 to 90 mm Hg, but FiO2 increased from 0.30 to 0.60. Document both settings and recognize that the higher oxygen tension alone cannot establish an improvement in pulmonary oxygen transfer.
Common pitfall: Comparing laboratory values without their support settings can make escalating respiratory failure appear to be recovery and can lead to premature support reduction.
AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
4.How can collection errors distort a blood-gas result?
Blood-gas validity depends on correct collection, adequate mixing, appropriate anticoagulation and prompt handling according to the laboratory's validated procedure. Air contamination drives gas tensions toward those of the contaminating air, while ongoing cellular metabolism can change an unprocessed specimen. Excess liquid anticoagulant can dilute the sample. When a result conflicts with the patient, inspect specimen quality and collection circumstances before changing treatment, while continuing assessment of any immediate clinical instability.
Apply it
A clinically unchanged patient has an unexpected gas result from a syringe containing a visible air bubble. Arrange a properly collected replacement specimen and review handling details before making a major ventilator adjustment solely from that result.
Common pitfall: Assuming every unexpected number represents disease progression can trigger harmful treatment; dismissing the patient while investigating the specimen is equally unsafe during instability.
AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
5.When is blood CO-oximetry needed despite a reassuring pulse oximeter?
Conventional two-wavelength pulse oximetry cannot reliably distinguish oxyhemoglobin from carboxyhemoglobin, so carbon monoxide poisoning may coexist with a reassuring displayed saturation. Blood CO-oximetry measures hemoglobin species and supports confirmation of suspected exposure. PaO2 can also remain relatively preserved because it measures dissolved oxygen rather than oxygen carried normally by hemoglobin. Interpret carboxyhemoglobin with exposure history and elapsed time since leaving the source or receiving oxygen; concentration alone does not reliably grade clinical severity.
Apply it
Two household members develop headache after using a generator indoors. One has SpO2 99%. Recommend blood CO-oximetry and urgent exposure-directed assessment rather than excluding poisoning because the pulse oximeter appears normal during the initial examination.
Common pitfall: Ordering only a standard PaO2 measurement misses the hemoglobin abnormality; a reassuring saturation or declining carboxyhemoglobin after oxygen does not erase a convincing exposure history.
Clinical Guidance for Carbon Monoxide Poisoning Following Disasters and Severe Weather
6.How should an implausible pulse-oximetry reading be checked?
Pulse oximetry estimates arterial oxygen saturation using a pulsatile optical signal. Poor circulation, movement, skin temperature, nail products and skin pigmentation can affect accuracy. Compare the displayed pulse with the patient's pulse, inspect signal quality, reposition the sensor and assess the patient directly. When the reading remains inconsistent with the clinical picture or a consequential decision depends on precision, obtain an appropriate blood measurement rather than repeatedly accepting an unreliable optical estimate.
Apply it
A cold, shivering patient's finger SpO2 fluctuates between 78% and 96%, and the displayed pulse differs from the ECG. Assess breathing, improve signal conditions and verify oxygenation through a suitable measurement if uncertainty persists.
Common pitfall: Treating a number without checking signal quality can produce unnecessary escalation; assuming artifact solely because the patient looks comfortable can also miss hypoxemia.
7.Which capillary blood-gas values are most useful in neonates and children?
A properly obtained capillary sample can support assessment of pH and carbon dioxide in selected neonatal and pediatric patients. Capillary PO2 is insufficiently reliable as a substitute for arterial oxygen tension, particularly when a precise oxygenation assessment is required. Sample interpretation also depends on peripheral perfusion and collection quality. Poor perfusion weakens agreement with arterial values, so a cold or poorly perfused infant requires particular caution before support is changed from capillary results.
Apply it
A premature infant has a useful capillary pH and PCO2 but a low capillary PO2. Assess oxygenation with pulse oximetry and, when needed, arterial sampling rather than increasing oxygen solely from the capillary oxygen value.
Common pitfall: Calling an arterialized capillary sample fully equivalent to arterial blood overstates its oxygenation accuracy, especially when peripheral perfusion is poor or collection is difficult.
8.How is the PaO2-to-FiO2 ratio calculated and interpreted?
The P/F ratio divides arterial oxygen tension in mm Hg by inspired oxygen expressed as a decimal fraction. It summarizes oxygenation relative to the supplied oxygen concentration and is useful for tracking a patient under documented support conditions. For example, PaO2 80 on FiO2 0.40 gives 200. The ratio alone does not establish an ARDS diagnosis, explain the mechanism of hypoxemia or replace consideration of PEEP, imaging, timing and the broader clinical picture.
Apply it
A ventilated patient's PaO2 is 72 mm Hg on FiO2 0.60. Calculate a P/F ratio of 120 and communicate the oxygenation impairment together with PEEP and current ventilator settings for a meaningful comparison.
Common pitfall: Dividing by 60 instead of 0.60 creates a hundredfold error; assigning a complete diagnosis from the ratio alone exceeds what this calculation establishes.
ARDS Network ALTA Protocol, Version II, October 31, 2007 · AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
9.Why can a normal minute ventilation coexist with carbon dioxide retention?
Minute ventilation equals respiratory frequency multiplied by tidal volume, but effective carbon dioxide elimination depends on alveolar ventilation. Each breath includes dead-space ventilation that does not participate in gas exchange. Rapid, shallow breathing can therefore preserve total minute ventilation while reducing the portion reaching functioning alveoli. Evaluate tidal volume, frequency, PaCO2 and the clinical setting together. A numerical minute-volume target should not substitute for assessment of ventilation effectiveness or the safety of the delivered breath.
Apply it
A patient changes from 12 breaths of 500 mL to 24 breaths of 250 mL each minute. Both patterns yield 6 L/min, but the shallow pattern devotes a larger fraction to dead-space ventilation.
Common pitfall: Assuming equal minute volumes guarantee equal PaCO2 ignores dead space; increasing tidal volume indiscriminately can improve a number while creating excessive lung stress.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
10.How do peak and plateau pressures separate resistance from elastic load?
During passive volume-controlled ventilation, peak pressure includes the pressure needed to overcome flow resistance plus the pressure distending the respiratory system. An inspiratory hold measures plateau pressure after flow stops. A rising peak pressure with a stable plateau suggests increased resistance, such as secretions or tubing obstruction. A rise in both suggests a greater elastic load or altered end-expiratory pressure. Interpret these relationships only when the measurement conditions are valid and the patient is not actively distorting the maneuver.
Apply it
Peak pressure rises from 25 to 38 cm H2O while plateau remains 21 during unchanged passive ventilation. Investigate airway and circuit resistance before concluding that lung compliance has suddenly fallen or increasing the pressure alarm limit.
Common pitfall: Using peak pressure as a direct measure of alveolar distending pressure confuses flow resistance with elastic pressure and can misdirect the response to an alarm.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
11.How is static respiratory-system compliance calculated?
Static compliance estimates the volume change produced by a change in respiratory-system distending pressure. During an appropriate passive measurement, divide tidal volume by plateau pressure minus total PEEP. Use consistent units, commonly mL/cm H2O. Total PEEP includes intrinsic PEEP when present; substituting only the set PEEP can distort the result. A falling compliance trend prompts assessment for increased elastic load, but the calculation does not distinguish lung stiffness from chest-wall contributions by itself.
Apply it
A passive patient receives 420 mL, plateau pressure is 26 cm H2O and total PEEP is 12. Static compliance is 420 divided by 14, or 30 mL/cm H2O, under the stated measurement conditions.
Common pitfall: Subtracting set PEEP when intrinsic PEEP is present miscalculates compliance; substituting peak pressure introduces resistive pressure into a measurement intended to assess elastic behavior.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
12.Which measurements support recognition of intrinsic PEEP?
Intrinsic PEEP develops when expiration is incomplete before the next breath. Expiratory flow that has not returned to zero at the next inspiration suggests ongoing emptying. In a passive patient, an end-expiratory hold can measure total PEEP, and subtracting set PEEP estimates intrinsic PEEP. Active respiratory effort and some flow-limited conditions complicate interpretation. Relate the findings to expiratory time, obstruction, triggering difficulty and hemodynamics rather than treating a single waveform as a complete diagnosis.
Apply it
Set PEEP is 5 cm H2O, but a valid expiratory hold measures total PEEP of 11. Estimate intrinsic PEEP at 6 cm H2O and review expiratory flow and available exhalation time before changing support.
Common pitfall: A ventilator's set PEEP does not reveal the entire end-expiratory pressure; an actively breathing patient's hold maneuver may also give a misleading value.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
13.What spirometric finding establishes an obstructive ventilatory pattern?
An FEV1/FVC below the appropriate lower limit of normal supports an obstructive ventilatory impairment when the maneuvers are technically acceptable. The ratio compares early forced expiratory flow with the total forced expired volume. Interpret it using suitable reference values and clinical context rather than applying an arbitrary percent-predicted threshold to every measurement. Spirometry identifies a physiological pattern; it does not independently distinguish asthma, COPD and every other cause of airflow obstruction in an individual patient.
Apply it
A technically acceptable study has FEV1/FVC below its reported lower limit of normal. Identify obstruction, then integrate symptoms, exposures and bronchodilator response instead of naming a specific disease solely from the reduced ratio on that study.
Common pitfall: A low FEV1 alone does not establish obstruction; it may accompany restriction, poor effort or other patterns that require interpretation of the complete study.
ERS/ATS Technical Standard on Interpretive Strategies for Routine Lung Function Tests (2022)
14.Why does a low FVC require lung-volume confirmation of restriction?
Restriction is established physiologically by a total lung capacity below the lower limit of normal. A reduced FVC with a preserved FEV1/FVC can suggest restriction, but incomplete inspiration, early termination or air trapping can produce a similar spirometric appearance. First assess test quality, then obtain lung volumes when confirmation will affect the clinical interpretation. If both the ratio and FVC are low, lung volumes also help distinguish obstruction with air trapping from a mixed impairment.
Apply it
An acceptable spirometry report shows a preserved FEV1/FVC and low FVC. Recommend measurement of total lung capacity before labeling the patient as having confirmed restrictive disease or choosing treatment based on that label alone.
Common pitfall: Equating every low FVC with restriction confuses a screening clue with its confirming measurement and can overlook obstruction with substantial air trapping or technical limitation.
ERS/ATS Technical Standard on Interpretive Strategies for Routine Lung Function Tests (2022)
15.How does the 2022 ERS/ATS standard express bronchodilator responsiveness?
The 2022 ERS/ATS interpretive standard expresses a significant bronchodilator response as a change greater than 10% of the predicted value in FEV1 or FVC. Calculate the post-treatment minus pre-treatment change and divide by the predicted value for that variable, then multiply by 100. This denominator differs from the patient's baseline measurement. Responsiveness describes a physiological change and does not independently prove asthma or exclude COPD, while an absent response does not exclude clinically important airway disease.
Apply it
Predicted FEV1 is 3.0 L, baseline is 1.5 L and post-bronchodilator FEV1 is 1.8 L. The change is 10% of predicted, which does not exceed the standard's greater-than-10% threshold for that variable.
Common pitfall: Using baseline FEV1 as the denominator answers a different question; rounding a result at the threshold upward can incorrectly convert a borderline change into responsiveness.
ERS/ATS Technical Standard on Interpretive Strategies for Routine Lung Function Tests (2022)
16.How should persistent focal atelectasis on imaging change the diagnostic plan?
Interpret a persistent lobar or segmental atelectasis report as a localized loss of aeration that requires an explanation, rather than assuming every opacity represents pneumonia. Compare prior imaging, airway position, secretion findings and response to clearance treatment. The 2007 AARC bronchoscopy-assisting guideline identifies persistent atelectasis, recurrent pneumonia and suspected mucus-plug obstruction as indications for bronchoscopic evaluation. Bronchoscopy can inspect airway patency and obtain specimens when the unresolved question concerns an obstructing process or lower-airway disease.
Apply it
Serial chest radiographs report persistent right-upper-lobe atelectasis despite effective routine secretion management. Recommend evaluation for a focal airway obstruction, including bronchoscopy when indicated, rather than treating the unchanged opacity as proof that more bronchodilator is required.
Common pitfall: A focal opacity does not establish its cause. Repeatedly prescribing the same clearance treatment without reviewing persistent localized collapse can delay identification of an obstructing lesion or retained material.
bronchoscopy_assisting.pdf · Therapist Multiple-Choice Examination Detailed Content Outline
17.How should imaging and symptoms be interpreted after transbronchial biopsy?
Pneumothorax is a recognized complication of transbronchial biopsy. New pleural air with lung collapse on a postprocedure chest radiograph provides a structural explanation for new dyspnea or hypoxemia and requires prompt clinical assessment. The 2007 AARC bronchoscopy-assisting guideline describes a chest radiograph one hour after transbronchial biopsy to exclude pneumothorax. New symptoms or instability require immediate evaluation rather than waiting for the planned image. Assess breath sounds, oxygenation, blood pressure and respiratory effort together with the imaging result.
Apply it
After biopsy, a patient develops new chest pain, dyspnea and unilateral reduction in breath sounds. Promptly assess for pneumothorax and obtain urgent assistance and imaging as the patient's condition permits; hypotension makes this more urgent.
Common pitfall: Attributing every postprocedure desaturation to sedation can miss a mechanical complication. Conversely, a radiographic pneumothorax must be interpreted with clinical stability when determining the urgency of intervention.
18.Why does medication reconciliation matter before interpreting bronchodilator response?
Recent bronchodilator use can affect baseline airway caliber, while concurrent medicines can modify treatment response or adverse effects. Beta blockers can antagonize albuterol's bronchodilation and may provoke bronchospasm. Non-potassium-sparing diuretics, including loop and thiazide drugs, present a different interaction: beta agonists can worsen their associated hypokalemia and ECG effects, particularly with excessive beta-agonist dosing. This diuretic interaction is documented in section 7.2 of the albuterol HFA prescribing information. Establish each drug, dose and timing before interpreting poor relief or new adverse findings.
Apply it
Reduced albuterol relief after a new beta blocker suggests receptor antagonism. Palpitations with low potassium in a patient receiving albuterol and a loop diuretic instead suggest a compounded electrolyte and cardiovascular risk requiring assessment.
Common pitfall: The interactions have different mechanisms. A diuretic does not principally block beta receptors, and escalating albuterol without reviewing either interaction can worsen the clinical problem.
Albuterol Sulfate Inhalation Solution: Prescribing Information · DailyMed - ALBUTEROL SULATE HFA- albuterol sulfate aerosol, metered
19.How should new ECG changes during beta-agonist treatment be interpreted?
Albuterol can cause clinically significant changes in pulse or blood pressure and has been associated with T-wave flattening, QTc prolongation and ST-segment depression. Its potassium shift into cells can also contribute to hypokalemia. New palpitations with these findings warrant assessment of rhythm, perfusion, potassium, dose exposure and concurrent medicines. The HFA label cautions that non-potassium-sparing diuretics can compound hypokalemia and ECG effects. ECG changes are not specific enough to assign a medication cause without considering symptoms and competing cardiac disease.
Apply it
After frequent albuterol doses, a patient taking a loop diuretic develops palpitations, T-wave flattening and low potassium. Communicate the combined medication and electrolyte concern and reassess treatment rather than assuming the tracing proves worsening airflow obstruction.
Common pitfall: A faster heart rate is not evidence that bronchodilation succeeded. ST changes with chest pain also require assessment for ischemia rather than automatic attribution to albuterol.
DailyMed - ALBUTEROL SULATE HFA- albuterol sulfate aerosol, metered
20.Why must blood pressure and perfusion accompany interpretation of positive-pressure support?
In acute cardiogenic pulmonary edema, positive-pressure support can improve respiratory mechanics and reduce left-ventricular afterload by reducing large negative inspiratory pressure swings. Evaluate blood pressure, consciousness and peripheral perfusion alongside oxygenation and respiratory effort. A better SpO2 does not establish cardiovascular stability. The 2017 ERS/ATS recommendations supporting CPAP or bilevel NIV for cardiogenic pulmonary edema do not extend to cardiogenic shock, which was generally excluded from the trials. A substantial pressure fall changes the interpretation of apparent respiratory improvement.
Apply it
During NIV, SpO2 improves but blood pressure falls from 130/80 to 78/46 mm Hg with cool extremities and confusion. Interpret this as hemodynamic deterioration requiring urgent reassessment, rather than declaring success from oxygenation alone.
Common pitfall: Improved saturation can coexist with poor systemic perfusion. Evidence supporting NIV in cardiogenic pulmonary edema should not be applied unchanged to a patient developing shock.
21.Why can normal PaO2 coexist with reduced arterial oxygen content?
PaO2 measures oxygen dissolved in plasma, while most arterial oxygen is carried by hemoglobin. Oxygen content therefore depends strongly on hemoglobin concentration and functional hemoglobin saturation. A patient with severe anemia can have a normal PaO2 and saturation yet carry substantially less oxygen per unit of blood. Blood-gas and hemoximetry interpretation should distinguish tension, saturation and content. Delivery to tissues also depends on circulation, so a reassuring PaO2 alone does not establish adequate systemic oxygen delivery.
Apply it
Two patients have PaO2 95 mm Hg and saturation 98%, but one has markedly reduced hemoglobin. Recognize that their oxygen-carrying capacities differ and integrate the CBC with respiratory and circulatory assessment before interpreting tissue oxygen availability.
Common pitfall: Using PaO2 as a substitute for hemoglobin-bound oxygen misses anemia and dyshemoglobinemia; increasing oxygen concentration does not directly replace the missing oxygen-carrying protein.
AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
Troubleshooting and Quality Control of Devices, and Infection Control14.3% (20/140 scored items)
22.How should a high-pressure ventilator alarm be investigated?
A high-pressure alarm signals increased pressure somewhere in the patient-circuit system and requires immediate patient assessment. Inspect for distress, impaired ventilation, tube kinking, biting, pooled secretions and circuit obstruction. In a stable passive patient, compare peak and plateau pressures to distinguish increased flow resistance from increased elastic load. If effective ventilation is threatened, secure an effective means of ventilation while assistance arrives. Alarm limits should support detection of deterioration rather than conceal a newly developed mechanical problem.
Apply it
An intubated patient suddenly develops a high-pressure alarm and reduced delivered volume after repositioning. Inspect the airway and circuit for kinking while assessing chest movement and oxygenation, correcting the obstruction before accepting the new pressure as expected.
Common pitfall: Raising the pressure limit before identifying the cause can permit excessive pressure or prolong inadequate ventilation; silence an alarm only while actively evaluating its cause.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
23.Which findings suggest a ventilator leak or disconnection?
A new low-pressure alarm, loss of expected exhaled volume or inability to maintain pressure suggests a leak, disconnection or airway problem. Begin with the patient, then follow the circuit systematically from the airway connection through the tubing and humidification components. Inspect airway position and cuff pressure when appropriate. The volume discrepancy is a clue rather than a complete diagnosis. Restore effective ventilation promptly and reassess measured volume, pressure and clinical response after correcting the identified defect.
Apply it
After a circuit component is changed, exhaled tidal volume falls and the ventilator cannot sustain pressure. Examine the new connection and the full circuit, then confirm restored ventilation instead of increasing the set tidal volume to compensate.
Common pitfall: Increasing the prescribed volume can worsen delivery once a leak is corrected; a circuit explanation should never prevent assessment for airway displacement or a cuff problem.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
24.When is a heat-and-moisture exchanger unsuitable?
A heat-and-moisture exchanger conserves exhaled heat and water but adds apparatus dead space and resistance. The 2012 AARC guideline does not recommend HMEs during low-tidal-volume ventilation because added dead space can increase ventilation requirements and PaCO2. It identifies thick, copious or frankly bloody secretions as contraindications. A contaminated or obstructed HME adds further resistance. When unsuitable, remove the HME and use an appropriate active heated-humidification system, verifying circuit compatibility and function. Required humidification continues during invasive ventilation.
Apply it
A patient receiving low tidal volumes develops hypercapnia and increased pressure with a secretion-soiled HME. Replace the HME humidification approach with suitable heated humidification and reassess pressures, ventilation and secretion conditioning.
Common pitfall: Replacing the soiled component with another HME leaves its dead-space burden in a patient for whom HMEs are discouraged. Removing humidification entirely creates a separate airway hazard.
25.How should condensate in a heated breathing circuit be managed?
Condensate forms when humidified gas cools below its dew point within the circuit. Accumulated water can obstruct flow, disturb triggering or move toward the airway. Inspect circuit positioning, water traps, humidifier function and temperature management. Remove accumulated condensate using infection-prevention procedures that prevent drainage into the patient. The objective is to preserve adequate humidification while maintaining a patent circuit. Simply eliminating humidification solves neither the patient's conditioning requirement nor the underlying circuit-management problem during invasive ventilation.
Apply it
A ventilator begins irregular triggering, and water is visible in a dependent tubing loop. Safely drain the condensate away from the patient and reassess triggering, then correct the circuit arrangement that allowed the accumulation to recur.
Common pitfall: Lifting a water-filled circuit above the airway can deliver condensate toward the patient; turning off required humidification substitutes a new hazard for the original problem.
26.How do noninvasive ventilation leaks affect treatment effectiveness?
Excessive interface leakage can reduce effective pressure support, impair triggering and cycling, disturb sleep or direct airflow into the eyes. First distinguish expected intentional venting from an unintended leak. Assess interface size, placement, connections and the patient's interaction with the device. Correction should improve synchrony without excessive strap pressure or skin injury. Persistent intolerance may require a different interface or support strategy, while worsening clinical failure requires reassessment beyond simply making the mask tighter against the face.
Apply it
A patient receiving bilevel ventilation has eye irritation, audible edge leakage and missed assisted breaths. Reposition and reassess the correctly sized interface, check synchrony and monitor response rather than repeatedly increasing strap tension and inspiratory pressure.
Common pitfall: Occluding an intentional exhalation port to stop a leak can impair safe gas clearance; overtightening can create pressure injury without fixing an unsuitable interface.
Official ERS/ATS Clinical Practice Guidelines: Noninvasive Ventilation for Acute Respiratory Failure (2017) · AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
27.Why can visible aerosol still produce ineffective medication delivery?
Visible mist confirms aerosol generation but does not establish that an effective dose reaches the lower airway. Leakage, a poor mask seal, incompatible components and incorrect device use can sharply reduce delivery. For a metered-dose inhaler with a valved holding chamber, inspect assembly and valve function as well as the patient's breathing technique. Match the interface to developmental ability and cooperation. Troubleshooting should observe the entire delivery sequence rather than judging success from aerosol production alone in the device.
Apply it
A young child's nebulizer produces mist, but the caregiver holds its mask several centimeters from the face. Explain and demonstrate a suitable sealed interface, then observe delivery before interpreting the persistent symptoms as medication failure requiring dose escalation.
Common pitfall: Treating blow-by mist as equivalent to a fitted interface overestimates delivery; increasing medication before correcting technique can create inconsistent exposure when technique later improves.
28.What constitutes passing spirometer calibration verification?
The 2019 ATS/ERS standard requires at least daily verification with a 3-L syringe cycled at least three times across flows spanning approximately 0.5–12 L/s. The measured volume at each flow must be within ±3%, equivalent to 2.91–3.09 L for a 3-L stroke. Verify inspiration and expiration when applicable to the device. If patient testing uses an in-line filter, install that filter during verification. A failure at one flow requires investigation and successful repeat verification before patient testing.
Apply it
Measurements of 2.94, 3.02 and 3.07 L at low, medium and high flows pass. Changing the high-flow result to 3.12 L produces a failure despite an acceptable average.
Common pitfall: A single convenient flow can miss flow-dependent error. Repeatable patient blows and averaging across syringe strokes cannot rescue an individual verification result outside tolerance.
Standardization of Spirometry 2019 Update: An Official ATS/ERS Technical Statement
29.What should happen when blood-gas analyzer quality control fails?
An unacceptable control requires investigation and correction before affected patient results are accepted. Check control handling, expiration, analyzer status and the relevant corrective procedure; demonstrate acceptable performance before resuming reporting. Evaluate potentially affected patient results from the unacceptable run and since the last acceptable run, as described in the CMS laboratory corrective-action guidance. Document corrective action and address results found unreliable. For urgent testing, use a validated alternative system while the failed analyzer is investigated.
Apply it
A control fails after several patient samples were analyzed. Stop reporting from the affected system, use a validated alternative for urgent specimens and assess potentially affected results back to the last acceptable run.
Common pitfall: A physiologically plausible result does not establish analytical accuracy. Repeating controls until one passes without explaining the failure can conceal an unresolved error.
AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013 · app-c_survey-procedures-igs-for-labs-labs-svcs-final.pdf
30.Which protections distinguish airborne precautions from patient source control?
Airborne precautions address organisms that remain infectious in suspended particles and require appropriate room placement and respiratory protection for personnel. CDC guidance includes an airborne infection isolation room and a fit-tested NIOSH-approved N95 or higher-level respirator for relevant conditions such as infectious pulmonary tuberculosis. During necessary transport, placing a surgical mask on the patient provides source control when tolerated. Standard Precautions continue to apply. The patient's mask and the clinician's respirator serve different functions and are not interchangeable.
Apply it
A patient with suspected infectious pulmonary tuberculosis needs necessary transport. Arrange airborne precautions, use the required staff respiratory protection and place a surgical mask on the patient if tolerated while coordinating the destination and minimizing unnecessary movement.
Common pitfall: Giving the patient an N95 does not replace staff respiratory protection; wearing a surgical mask for care requiring airborne respiratory protection provides a different level of control.
Initiation and Modification of Interventions50% (70/140 scored items)
31.When is artificial-airway suctioning indicated?
Suctioning removes secretions that the patient cannot adequately clear through an artificial airway. Indications include visible secretions, breath sounds suggesting retained secretions and ventilator waveform changes consistent with secretion accumulation. In neonates, an acute increase in airway resistance may indicate a need; the 2022 AARC guideline supports as-needed rather than scheduled suctioning for neonatal and pediatric patients. A high-pressure alarm alone does not establish retained secretions. Reassess airway patency and clinical response afterward.
Apply it
An intubated adult develops coarse breath sounds, visible tube secretions and a sawtooth flow waveform. These combined findings support suctioning, followed by reassessment of breath sounds, pressures and oxygenation.
Common pitfall: Routine suctioning without clinical indications adds procedural risk; assuming every pressure rise is caused by secretions can delay recognition of a kink or other cause.
AARC Clinical Practice Guidelines: Artificial Airway Suctioning (2022)
32.Which age-specific limits make artificial-airway suctioning safer?
Use shallow suctioning first; reserve deep suctioning for ineffective shallow attempts. The 2022 AARC guideline specifies catheter occlusion below 70% of the endotracheal-tube lumen in neonates and below 50% in pediatric and adult patients. Use the lowest effective vacuum, with magnitude below 120 mm Hg in neonatal and pediatric patients and below 200 mm Hg in adults; these are limits, not target settings. Apply suction for no longer than 15 seconds per procedure and use sterile technique for open suctioning. Preoxygenation is recommended for pediatric and adult patients; do not automatically extend that recommendation to neonatal hyperoxygenation.
Apply it
A pediatric patient requires suctioning. Select a catheter below the 50% lumen-occlusion limit, use effective vacuum below 120 mm Hg in magnitude and limit application to 15 seconds or less. A neonatal catheter follows the separate below-70% limit.
Common pitfall: More negative pressure is not inherently better. Confusing vacuum magnitude with its negative sign, using adult limits in children or advancing deeply on every pass increases risk.
AARC Clinical Practice Guidelines: Artificial Airway Suctioning (2022)
33.How should an adult artificial-airway cuff-pressure measurement guide action?
Measure cuff pressure directly with a manometer. The 2024 AARC assessment guideline discusses the commonly cited adult range of 20–30 cm H2O to balance sealing against tissue injury. Underinflation can permit leakage and microaspiration; overinflation can impair tracheal mucosal perfusion. If pressure is low, adjust cautiously and reassess the seal. Leakage persisting at an appropriate pressure requires investigation of tube position, cuff integrity or another cause rather than unlimited inflation. The guideline does not establish a universally mandated measurement interval.
Apply it
An adult has a cuff pressure of 14 cm H2O with an audible leak. Adjust within the adult range and reassess. If leakage persists at 26 cm H2O, investigate position and cuff integrity instead of continuing to add air.
Common pitfall: Pilot-balloon palpation cannot quantify pressure. A persistent leak is not permission to exceed the adult range without investigating why an adequate seal is absent.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
34.How should airway position be reassessed after patient movement?
Movement can alter an artificial airway's depth, security and relationship to the trachea. After repositioning or transport, reassess the documented depth mark, fixation, chest movement, breath sounds, delivered ventilation and exhaled carbon dioxide when available. A new change in ventilation or asymmetry requires prompt investigation. No single observation proves every aspect of correct placement. The practical decision is whether the airway remains secure and functionally effective, with additional confirmation obtained when the assessment suggests displacement or another complication.
Apply it
After transfer to a stretcher, an intubated patient's depth mark differs from its documented position and exhaled ventilation falls. Treat possible displacement as urgent, assess effective ventilation and obtain assistance before assuming a ventilator-setting problem explains the change.
Common pitfall: Continuing ventilation because the tube remains taped overlooks migration; a present carbon dioxide waveform does not by itself exclude an excessively deep tracheal position.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
35.Why does invasive ventilation require deliberate humidification?
An artificial airway bypasses the upper airway's normal warming and humidifying functions. Inadequately conditioned gas can impair secretion transport and contribute to thick secretions and airway obstruction. Provide humidification during invasive ventilation and assess whether the selected system meets the patient's needs. The 2012 AARC guideline discourages HMEs with low tidal volumes and contraindicates them with thick, copious or bloody secretions. In these circumstances, use suitable heated humidification and verify effective conditioning rather than leaving the circuit unhumidified.
Apply it
An invasively ventilated patient develops thick, copious secretions while using an HME. Change to suitable heated humidification, assess airway patency and provide indicated secretion clearance rather than repeatedly replacing the HME with the same unsuitable method.
Common pitfall: Dry tubing does not establish adequate airway conditioning; repeated suctioning cannot replace the humidity needed to prevent secretions from becoming progressively difficult to clear.
36.How should postoperative lung-expansion treatment be selected and taught?
For a cooperative postoperative patient taking shallow breaths because of pain, address analgesia, upright activity, deep breathing and directed coughing together. If incentive spirometry is selected, teach a slow sustained inspiration with a breath hold and observe performance. The AARC incentive-spirometry guidance advises against routine incentive spirometry alone for preventing postoperative complications; it belongs within a broader care plan. Selection requires assessing whether the patient can understand instructions, cooperate and perform the maneuver effectively.
Apply it
A painful postoperative patient cannot take a sustained breath. Coordinate analgesia, mobilization and coached breathing, then reassess inspiratory performance and tolerance before assuming that prescribing a device has provided effective expansion.
Common pitfall: Rapid repeated breaths or an unused device at the bedside do not establish effective expansion. Inability to cooperate undermines the technique and requires reconsideration of the approach.
37.How do preoxygenation and saline avoidance improve suctioning safety?
Suctioning can transiently impair oxygenation and ventilation, particularly in patients with limited reserve. The 2022 AARC guideline recommends preoxygenation in pediatric and adult patients and generally avoiding routine normal-saline instillation. Neonatal oxygen management requires separate consideration rather than automatic application of pediatric/adult hyperoxygenation. Saline is not a dependable substitute for adequate humidification. Monitor tolerance, use the age-specific catheter and vacuum limits, and keep suction application within 15 seconds. Stop sooner for significant intolerance and reassess before another attempt.
Apply it
An adult with limited oxygen reserve needs indicated suctioning. Preoxygenate, use sterile technique if suctioning is open, avoid routine saline and stop the application within 15 seconds or sooner if significant intolerance occurs.
Common pitfall: Preoxygenation does not make prolonged suctioning safe. Automatic saline instillation adds an intervention without correcting the underlying humidification requirement.
AARC Clinical Practice Guidelines: Artificial Airway Suctioning (2022)
38.Which oxygen target does the 2022 AARC guideline give hospitalized adults with COPD?
The 2022 AARC acute-care oxygen guideline recommends an SpO2 target of 88–92% for hospitalized adults with COPD. Oxygen should be titrated to the relevant target while clinical status and, when indicated, blood gases are assessed. This range addresses the balance between treating hypoxemia and avoiding unnecessary oxygen exposure in the specified population. It does not justify withholding oxygen from a severely hypoxemic patient, and saturation alone does not identify accompanying hypercapnia or ventilatory failure.
Apply it
A hospitalized adult with COPD has a reliable SpO2 of 86%. Increase oxygen toward 88–92% under the stated guideline and assess ventilation if somnolence, worsening distress or other findings suggest carbon dioxide retention during treatment.
Common pitfall: Withholding oxygen because the patient has COPD leaves hypoxemia untreated; targeting 100% routinely ignores the guideline's population-specific range and the need for reassessment.
39.How should oxygen therapy be adjusted after its initial prescription?
Oxygen is titrated to a defined clinical target rather than left at the initial flow regardless of response. The 2022 AARC guideline recommends 94–98% for most hospitalized adults and 88–92% for those with COPD. Reassess signal reliability, device performance, work of breathing and oxygen requirement after changes. A rising requirement can signal deterioration even when saturation remains within range. Once excessive support is no longer required, reduce it while ensuring the patient continues to meet the applicable target.
Apply it
A hospitalized adult without COPD remains at SpO2 100% on supplemental oxygen after recovery from an acute episode. Reduce support in a monitored manner toward the guideline's target and confirm that oxygenation remains adequate after the adjustment.
Common pitfall: A normal saturation achieved with steadily increasing oxygen can conceal worsening gas exchange; leaving a high flow unchanged after recovery overlooks a meaningful opportunity to titrate.
40.When is bilevel noninvasive ventilation supported in a COPD exacerbation?
The ERS/ATS guideline supports bilevel NIV for acute or acute-on-chronic respiratory acidosis caused by a COPD exacerbation in an appropriate patient. Relevant cues include pH at or below 7.35, elevated PaCO2 and persistent respiratory distress despite standard treatment. The patient must be assessed for cooperation, airway protection and immediate need for invasive ventilation. NIV reduces the work required for ventilation, but its use demands close reassessment and access to escalation if clinical response is inadequate.
Apply it
An alert, cooperative patient with COPD remains distressed after initial treatment, with pH 7.29 and PaCO2 62 mm Hg. Recommend closely monitored bilevel NIV when airway protection is adequate and no immediate indication for intubation is present.
Common pitfall: Hypercapnia without acidosis is not the same indication; starting NIV in a patient unable to protect the airway can delay the support actually required.
41.Which early changes suggest noninvasive ventilation is failing?
Effective NIV should improve the patient's clinical trajectory, commonly including respiratory effort, respiratory rate and acid-base status in acidotic COPD. Worsening acidosis, increasing distress, declining consciousness or inability to manage the interface and airway require urgent reassessment. Check correctable delivery problems, but do not let repeated mask adjustments postpone escalation during deterioration. The lower the pH and the more unstable the patient, the greater the need for close observation and rapid access to invasive ventilation when indicated.
Apply it
After NIV begins, a patient's respiratory distress intensifies and alertness declines while pH falls further. Seek urgent escalation and assess airway protection while checking delivery, instead of continuing successive pressure increases without a clear improvement in the patient's condition.
Common pitfall: Improved displayed pressure does not prove improved ventilation; attributing every failure to mask fit can prolong an ineffective trial in a patient requiring definitive airway support.
42.How do CPAP and bilevel NIV differ in acute cardiogenic pulmonary edema?
CPAP maintains positive pressure throughout breathing, whereas bilevel NIV adds a higher inspiratory pressure above the expiratory pressure and can provide additional ventilatory assistance. The ERS/ATS guideline supports either CPAP or bilevel NIV for suitable patients with acute respiratory failure from cardiogenic pulmonary edema. Selection depends on the clinical need, tolerance and available expertise. Evaluate blood pressure, work of breathing and response, and recognize that noninvasive support is not a substitute for addressing the underlying cardiac problem.
Apply it
A cooperative patient with cardiogenic pulmonary edema has severe respiratory distress and preserved blood pressure. Consider CPAP or bilevel NIV with close monitoring while the team treats the cardiac cause and reassesses whether noninvasive support is sufficient.
Common pitfall: Assuming CPAP supplies a separate inspiratory pressure boost confuses the modes; positive pressure can also affect circulation, so respiratory improvement must be assessed alongside hemodynamics.
43.Why is protective tidal volume based on predicted body weight?
Lung size relates more closely to height and the sex-specific formula used for predicted body weight than to excess body mass. Protective-volume calculations therefore use predicted rather than actual weight. In the historical ARDS Network protocol, male PBW equals 50 plus 2.3 times inches above 60, and female PBW equals 45.5 plus the same height term. These formulas support arithmetic practice; current ventilation decisions also require assessment of plateau pressure, delivered volume, gas exchange and patient tolerance.
Apply it
For a 70-inch male, historical protocol PBW is 50 plus 2.3 times 10, or 73 kg. At a stated exercise target of 6 mL/kg PBW, calculate 438 mL despite a much greater actual weight.
Common pitfall: Using actual weight in severe obesity can substantially overestimate tidal volume; reproducing historical arithmetic does not make the entire historical protocol a current comprehensive treatment recommendation.
ARDS Network ALTA Protocol, Version II, October 31, 2007 · AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
44.How does plateau pressure guide protective-ventilation reassessment?
Plateau pressure measured during an appropriate inspiratory hold estimates end-inspiratory respiratory-system pressure without the resistive component created by flow. The 2024 AARC assessment guideline emphasizes assessing plateau pressure in lung-protective ventilation, commonly targeting no more than 30 cm H2O in the relevant strategy. An elevated value prompts review of tidal volume, mechanics and measurement validity. It should not be interpreted as a direct isolated measure of lung tissue stress when chest-wall loading or active effort substantially alters the measurement.
Apply it
A passive patient's plateau pressure is 34 cm H2O during a valid hold. Reassess delivered tidal volume and respiratory mechanics within the protective strategy, rather than accepting the setting because peak pressure has remained unchanged during the shift.
Common pitfall: A low peak-pressure alarm setting does not establish a safe plateau pressure; a plateau obtained during active effort may misrepresent the pressure of interest.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
45.How does driving pressure connect tidal volume with respiratory mechanics?
During appropriate passive measurements, driving pressure is plateau pressure minus total PEEP and equals tidal volume divided by static respiratory-system compliance. It describes the pressure change associated with delivering the breath above end-expiratory pressure. Assess it alongside tidal volume, plateau pressure and total PEEP when evaluating protective ventilation. A change after adjusting PEEP requires remeasurement because recruitment, overdistention and intrinsic PEEP can alter the relationship. One calculated value should not automatically dictate a PEEP change without clinical assessment.
Apply it
Plateau pressure is 28 cm H2O and total PEEP is 12, giving driving pressure 16. After a setting change, repeat both measurements and evaluate the patient's response rather than assuming driving pressure changed by the set-PEEP difference alone.
Common pitfall: Subtracting only set PEEP when intrinsic PEEP is present misstates driving pressure; increasing PEEP does not guarantee that the resulting pressure-volume relationship becomes more favorable.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
46.How can ventilator timing reduce incomplete exhalation?
When expiratory flow persists into the next inspiration, assess whether the patient has enough time to empty the lungs. Review respiratory rate, inspiratory time, tidal volume and airway resistance. Increasing available expiratory time and treating reversible resistance can reduce dynamic hyperinflation, but adjustments must preserve adequate gas exchange and patient tolerance. Reassess the flow waveform and total PEEP after intervention. A higher rate intended to lower PaCO2 can have the opposite effect when it worsens trapping and ineffective ventilation.
Apply it
A ventilated patient with obstruction has persistent end-expiratory flow and measurable intrinsic PEEP. Review timing to allow longer exhalation and assess treatable resistance, then repeat mechanics and gas-exchange assessment before judging whether the change has been effective.
Common pitfall: Increasing respiratory rate reflexively for hypercapnia can shorten exhalation and worsen trapping; a waveform should be interpreted with valid pressure measurements and the patient's clinical response.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
47.Why should ventilator dyssynchrony be investigated before escalating sedation?
Dyssynchrony occurs when ventilator delivery does not match the patient's respiratory timing or demand. Potential contributors include inadequate flow, triggering difficulty, leaks, inappropriate cycling and intrinsic PEEP. Compare the patient's effort with pressure and flow waveforms, then address the identified mechanism. Sedation may sometimes be part of the broader plan, but it does not correct a disconnected circuit or unsuitable trigger setting. The goal is effective, tolerable support while retaining appropriate protective limits and reassessing the response to each change.
Apply it
A patient repeatedly makes visible inspiratory efforts that fail to trigger assisted breaths. Assess triggering and intrinsic PEEP with the waveforms before recommending more sedation solely because the patient appears to be fighting the ventilator during each attempt.
Common pitfall: Labeling every mismatch as agitation can obscure a correctable setting or mechanical problem; eliminating visible effort does not prove that ventilator delivery has become physiologically appropriate.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
48.How should elevated PaCO2 be addressed during protective ventilation?
An elevated PaCO2 during protective ventilation requires assessment of pH, clinical tolerance, effective minute ventilation, dead space and expiratory mechanics. Increasing tidal volume may lower PaCO2 but can undermine protection if it raises distending pressure excessively. Review reversible causes such as obstruction, added apparatus dead space or inadequate delivered ventilation. Rate adjustments also require enough expiratory time. When an HME is present during low-tidal-volume ventilation, change to suitable heated humidification rather than retaining the discouraged dead-space burden.
Apply it
PaCO2 rises after an HME is added to a low-volume circuit. Replace that humidification approach with appropriate heated humidification, reassess delivered ventilation and evaluate pH and tolerance before increasing tidal volume beyond the protective plan.
Common pitfall: Normalizing PaCO2 through an unsafe tidal volume trades one abnormality for a ventilation hazard; increasing rate without reviewing exhalation can worsen intrinsic PEEP instead.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024) · AARC Clinical Practice Guideline: Humidification During Invasive and Noninvasive Mechanical Ventilation: 2012
49.When should readiness for a spontaneous breathing trial be assessed?
Readiness assessment asks whether the acute reason for ventilation has improved enough to attempt breathing with minimal assistance. Review spontaneous effort, oxygenation, hemodynamic stability and the broader clinical trajectory. The 2024 AARC guideline supports a standardized approach to daily assessment and does not require the rapid shallow breathing index as a gatekeeper. Avoid unnecessary delay from waiting for one favored number when the overall assessment supports a trial, while recognizing that persistent instability can make the trial inappropriate at that time.
Apply it
A patient's acute illness is improving, spontaneous effort is present and oxygenation and circulation are stable. Arrange the standardized readiness assessment and an appropriate trial instead of postponing solely because nobody has calculated a rapid shallow breathing index.
Common pitfall: A mandatory index can become an unsupported barrier to timely evaluation; conversely, an improving laboratory result alone does not establish readiness when clinical instability persists.
50.Which neonatal problem is inhaled nitric oxide intended to address?
The 2010 AARC neonatal inhaled nitric oxide guideline addresses term and near-term neonates with hypoxic respiratory failure and pulmonary hypertension. Inhaled nitric oxide selectively dilates pulmonary vessels serving ventilated lung regions, addressing elevated pulmonary vascular resistance while supporting oxygenation. It is used alongside effective ventilatory support. The discriminating cues are the neonatal population, persistent hypoxemia and evidence of pulmonary hypertension; hypoxemia by itself does not establish this specific treatment indication.
Apply it
A term neonate remains hypoxemic despite respiratory support, and echocardiography identifies pulmonary hypertension. These findings support consideration of prescribed inhaled nitric oxide. Compare oxygenation before and after initiation under documented ventilator and oxygen settings to assess the response.
Common pitfall: Inhaled nitric oxide does not replace adequate lung ventilation. The neonatal indication does not justify routine treatment of every hypoxemic infant or automatic extension to adults with unrelated causes of hypoxemia.
51.Which hazards require monitoring during inhaled nitric oxide?
Monitor delivered nitric oxide concentration, nitrogen dioxide and blood methemoglobin during treatment. Nitrogen dioxide can injure the lungs, while methemoglobin reduces functional oxygen carriage. These hazards require separate assessments because an improved PaO2 does not establish that hemoglobin function or delivered gas concentrations are safe. The 2010 AARC neonatal guideline also advises gradual withdrawal: abrupt interruption can produce rebound pulmonary hypertension and hypoxemia. Delivery continuity is therefore a clinical requirement during equipment changes and transport.
Apply it
Before transporting a neonate receiving inhaled nitric oxide, verify continuous delivery, appropriate monitoring and backup capability. If hypoxemia develops, investigate delivery interruption and methemoglobinemia alongside changes in lung disease or ventilatory support.
Common pitfall: Improved oxygen tension does not exclude impaired hemoglobin function. Abruptly stopping an apparently effective treatment can cause rebound deterioration rather than demonstrate that treatment is no longer needed.
52.Why does a successful breathing trial not automatically justify extubation?
A successful SBT demonstrates tolerance of reduced ventilator assistance under documented conditions. The 2024 AARC guideline permits trials with or without pressure support and suggests not increasing FiO2 during the trial. Follow respiratory effort, oxygenation and cardiovascular response; a favorable index cannot override intolerance. Even after success, assess airway protection, secretion management, cough and potential upper-airway problems. A patient may breathe adequately through a tube yet be unable to keep the airway clear after removal.
Apply it
A patient tolerates an SBT but has a weak cough and needs frequent secretion removal. Raise the unresolved clearance concern during extubation planning rather than recommending removal based only on stable respiratory rate and saturation.
Common pitfall: Equating ventilator independence with airway independence overlooks secretion burden and protection. Increasing oxygen to conceal trial intolerance can also overstate readiness.
53.How does albuterol relieve reversible bronchospasm?
Albuterol stimulates beta-adrenergic receptors with relative beta2 selectivity, increasing intracellular cyclic AMP and relaxing bronchial smooth muscle. The expected therapeutic effect is improved airflow when reversible bronchoconstriction contributes to symptoms. Assess breathing, airflow and tolerance after delivery rather than assuming every wheeze or episode of dyspnea has the same mechanism. Tachycardia, tremor and other adverse effects can limit treatment. A poor response requires review of delivery, diagnosis and the care plan rather than automatic repeated administration without reassessment.
Apply it
After prescribed albuterol, a patient reports easier breathing and shows improved airflow but develops troublesome palpitations. Document both benefit and adverse effects and communicate them when reconsidering the plan instead of recording the treatment as simply successful.
Common pitfall: Albuterol relaxes airway smooth muscle but does not directly remove a mucus plug or correct every cause of dyspnea; side effects are not proof of effective lung delivery.
Albuterol Sulfate Inhalation Solution: Prescribing Information
54.When should worsening bronchospasm during albuterol lead to treatment termination?
Albuterol can cause paradoxical bronchospasm, an unexpected worsening of airway obstruction during treatment that can be life-threatening. The prescribing information directs immediate discontinuation and institution of alternative therapy when it occurs. The decisive cue is acute worsening temporally associated with administration, rather than a delayed lack of improvement alone. Assess airway and breathing urgently, stop the suspected treatment and communicate the event. Repeating the same medication to overcome an immediate adverse response can intensify the problem rather than solve it.
Apply it
Within moments of starting a new albuterol unit dose, a patient's wheeze and distress abruptly worsen. Stop administration, assess respiratory status and obtain alternative treatment promptly rather than continuing until the nebulizer chamber empties during the suspected adverse reaction.
Common pitfall: Interpreting immediate deterioration as proof that more of the same bronchodilator is needed can worsen paradoxical bronchospasm; inadequate baseline response alone does not establish this reaction.
Albuterol Sulfate Inhalation Solution: Prescribing Information
55.Which aerosol interface fits a young child who cannot coordinate inhalation?
Aerosol-device selection should match developmental ability, breathing pattern and cooperation. A young child unable to coordinate a pressurized inhaler can receive medication through an appropriate valved holding chamber with a well-fitting mask, using the instructed breathing technique. A nebulizer with a suitable interface is another option when clinically appropriate. The key is reliable delivery through an interface the child can use. Age alone is less informative than observing whether the child can seal, breathe through and tolerate the chosen system.
Apply it
A toddler cannot coordinate actuation and inhalation from a pressurized inhaler. Select an age-appropriate chamber and fitted mask, coach the caregiver and observe the child's breathing through the system rather than asking for an adult inhaler maneuver.
Common pitfall: Holding a mask near a crying child's face does not assure an effective dose; choosing a device the caregiver cannot demonstrate undermines an otherwise appropriate prescription.
56.How does inhalation technique differ between dry-powder and pressurized inhalers?
For conventional pMDI use, begin a slow inspiration and actuate near its beginning, continue inhaling slowly and deeply, then hold the breath when feasible. A compatible valved holding chamber reduces the coordination demand; give one actuation at a time and use its instructed inhalation sequence. A young child may use tidal breathing through a well-fitting chamber mask. A DPI instead requires the device-appropriate rapid, sufficiently forceful inspiration to disperse powder. Assess actual inspiratory capability because weakness or acute distress may make a DPI unsuitable.
Apply it
A patient uses the same slow inhalation for a DPI as for a pMDI. Demonstrate the DPI's required rapid inhalation, observe performance and select another delivery method if the patient cannot generate it.
Common pitfall: A fast pMDI inspiration increases upper-airway deposition, while an insufficient DPI inspiration may fail to disperse powder. A spacer is not added to a DPI.
57.How should suspected carbon monoxide poisoning change immediate respiratory care?
CDC guidance recommends administering 100% oxygen for carbon monoxide poisoning until the patient is symptom-free, commonly for several hours, with serial neurological assessment. Clinical severity and circumstances guide consideration of hyperbaric oxygen consultation, particularly with serious neurological or cardiac involvement and in pregnancy. Conventional pulse oximetry is unreliable for excluding poisoning. Begin exposure-directed care promptly while obtaining appropriate testing; waiting for an abnormal displayed saturation can delay treatment because that measurement does not distinguish carboxyhemoglobin reliably from oxyhemoglobin.
Apply it
A patient rescued from an enclosed generator exposure has headache and confusion despite SpO2 100%. Provide high-concentration oxygen and urgent evaluation with blood CO-oximetry, while documenting neurological findings and exposure details for assessment of further treatment needs.
Common pitfall: Applying a routine saturation-based oxygen-weaning rule to suspected carbon monoxide poisoning overlooks the measurement limitation; carboxyhemoglobin concentration alone cannot summarize the patient's neurological or cardiac risk.
Clinical Guidance for Carbon Monoxide Poisoning Following Disasters and Severe Weather
58.How should respiratory support be reassessed during patient transport?
Transport changes the care environment, so reassess whether the airway, support device, oxygen supply and monitoring can maintain the patient's needs throughout the move. Document baseline settings and clinical status, then verify effective delivery after each transfer or reconnection. Secure the airway and circuit, anticipate interruptions and communicate the support requirement to the receiving team. Portable equipment displaying the prescribed setting does not alone prove equivalent ventilation. Patient assessment remains essential because movement can introduce disconnection, displacement, leakage or a new tolerance problem.
Apply it
Before moving a ventilated patient to imaging, verify portable support and monitoring against the baseline requirement. After transfer to the transport system, confirm chest movement, delivered ventilation and oxygenation before leaving the unit and communicate any change to the team.
Common pitfall: Checking equipment only before movement misses failures introduced during transfer; copying settings without confirming delivered support can overlook device differences, leaks or altered patient interaction.
AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024) · Therapist Multiple-Choice Examination Detailed Content Outline
59.What must the respiratory assistant prepare and monitor for bronchoscopy?
The AARC Bronchoscopy Assisting guideline, revised in 2007, assigns concrete preparation, monitoring, specimen and recovery responsibilities. Verify consent and the plan; check scope function, light source, suction and accessory compatibility. For an intubated patient, prepare an appropriate scope/ventilator adapter and an oxygenation and ventilation plan because scope insertion can increase resistance and impair ventilation. Have resuscitation and emergency airway equipment available, with capability to respond to bleeding or pneumothorax. Monitor consciousness, SpO2, FiO2, ECG, blood pressure, capnography and relevant ventilator pressures and volumes. Label specimens by patient, site and requested test using suitable containers. Continue postprocedure assessment of breathing, circulation, consciousness and complications.
Apply it
During bronchoscopy for persistent lobar collapse, peak pressure rises and exhaled volume and SpO2 fall. Alert the bronchoscopist, coordinate a pause or scope withdrawal to restore ventilation, support oxygenation and reassess. Afterward, document response and specimens; investigate new chest pain, bleeding or unilateral breath-sound changes promptly.
Common pitfall: Visible oxygen flow does not prove adequate ventilation around the scope. Unlabeled washings can invalidate diagnostic work, and recovery monitoring must continue beyond scope removal.
60.How does return demonstration establish whether home-care teaching worked?
Education is effective when the patient or caregiver can perform the required task and explain the important decisions, not merely agree that instructions were understood. Assess literacy, language, physical ability, developmental needs and available support, then teach in manageable steps. Ask for a return demonstration using the actual equipment and correct observed errors. Reassessment identifies whether difficulty comes from knowledge, dexterity, device choice or another barrier. Document demonstrated competence and remaining needs so the home plan matches the learner's capabilities.
Apply it
A caregiver says tracheostomy-care instructions are clear but omits an essential step during demonstration. Revisit that step, identify the reason for the omission and observe another complete demonstration before considering the teaching objective achieved for safe home performance.
Common pitfall: A signed handout or verbal agreement does not establish practical skill; repeating the same explanation without identifying the barrier can leave the learner unable to perform.
AARC Clinical Practice Guideline: Providing Patient and Caregiver Training (2010)
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Separate oxygenation, ventilation, oxygen content and circulatory perfusion before choosing a test or intervention.
- Interpret blood gases with baseline physiology, specimen quality and the support settings present at collection.
- Connect persistent focal imaging abnormalities and postprocedure changes with targeted diagnostic decisions.
- Interpret new ECG and blood-pressure changes alongside medications, electrolytes and respiratory support.
- Use peak pressure, plateau pressure, total PEEP, compliance and waveforms to distinguish resistance, elastic load and incomplete exhalation.
- Practise decimal FiO2, P/F ratios, predicted-body-weight tidal volumes and pressure calculations with explicit units.
- Apply operational criteria for spirometry verification, suctioning, cuff pressure and humidification selection.
- Match oxygen, NIV, lung expansion, specialty-gas monitoring and liberation decisions to indications and response.
- Include neonatal sampling and nitric oxide cases and pediatric aerosol examples while extending age-specific study with the full outline.
A practical preparation plan
1. Map study to the three-domain blueprint
Use the complete TMC outline as a coverage tracker. Begin with roughly half of study time on interventions, about one third on patient data, and the remainder on devices, quality control and infection prevention; adjust for demonstrated weaknesses.
2. Build a measurement-to-decision routine
For each case, identify the clinical problem, verify the measurement, interpret it under the stated conditions, choose the action and specify what improvement or failure would look like.
3. Practise mechanics and arithmetic together
Calculate P/F, minute ventilation, static compliance, intrinsic PEEP and driving pressure. Then explain the assumptions and the treatment error that an incorrect denominator or pressure measurement could cause.
4. Rehearse equipment and procedural reassessment
Work through alarms, leaks, humidification problems, verification failures and bronchoscopy complications. Start with the patient, inspect systematically and verify the clinical effect after correcting the suspected cause.
5. Review every distractor
Complete the 20 questions independently. Explain why each alternative is less appropriate, classify the error by domain and revisit the related concept before trying a new case.
6. Close coverage gaps with the official outline
After mastering these selected concepts, review every remaining outline subtopic and patient condition. Use NBRC's official practice resources for examination-software familiarity and broader preparation, while keeping the TMC-to-RT transition date in view.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Certified Respiratory Therapist (CRT)
- Therapist Multiple-Choice Examination Detailed Content Outline
- NBRC Candidate Handbook
- The Respiratory Therapy Examination Detailed Content Outline
- AARC Clinical Practice Guidelines
- AARC Clinical Practice Guideline: Blood Gas Analysis and Hemoximetry: 2013
- AARC Clinical Practice Guideline: Patient-Ventilator Assessment (2024)
- ERS/ATS Technical Standard on Interpretive Strategies for Routine Lung Function Tests (2022)
- Standardization of Spirometry 2019 Update: An Official ATS/ERS Technical Statement
- Clinical Guidance for Carbon Monoxide Poisoning Following Disasters and Severe Weather
- FDA Warns About Limitations and Accuracy of Pulse Oximeters
- AARC Clinical Practice Guidelines: Capillary Blood Gas Sampling for Neonatal and Pediatric Patients (2022)
- Transmission-Based Precautions
- AARC Clinical Practice Guideline: Humidification During Invasive and Noninvasive Mechanical Ventilation: 2012
- AARC Clinical Practice Guidelines: Artificial Airway Suctioning (2022)
- ARDS Network ALTA Protocol, Version II, October 31, 2007
- AARC Clinical Practice Guideline: Management of Adult Patients With Oxygen in the Acute Care Setting (2022)
- Official ERS/ATS Clinical Practice Guidelines: Noninvasive Ventilation for Acute Respiratory Failure (2017)
- AARC Clinical Practice Guideline: Spontaneous Breathing Trials for Liberation From Adult Mechanical Ventilation (2024)
- Albuterol Sulfate Inhalation Solution: Prescribing Information
- AARC Clinical Practice Guideline: Aerosol Delivery Device Selection for Spontaneously Breathing Patients: 2012
- AARC Clinical Practice Guideline: Providing Patient and Caregiver Training (2010)
- Client Challenge
- DailyMed - ALBUTEROL SULATE HFA- albuterol sulfate aerosol, metered
- American Thoracic Society | Interpretation of ABGs
- Federal Register :: Request Access
- app-c_survey-procedures-igs-for-labs-labs-svcs-final.pdf
- bronchoscopy_assisting.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.